Protein Metrics Pushes Biotherapeutic Development Analysis

SAN CARLOS, Calif., June 6, 2016 /PRNewswire-iReach/ -- Protein Metrics, Inc., today released powerful Intact Mass 1.2 updates that enable researchers to maximize all of their intact mass data quickly with new and extremely refined levels of analysis from low or high resolution mass spectrometers from all major vendors.

Photo - http://photos.prnewswire.com/prnh/20160602/375075

“Intact Mass is the only commercially available software that operates on vendor-neutral platforms and supports the kind of rigorous therapeutic protein investigation that biopharma labs most need,” says Eric Carlson, Ph.D., VP and Chief Business Officer. “The software’s algorithms provide efficient, clean processing of the raw data, enabling identification and the ability to inspect small features while preserving relative quantification found in the raw signal. By avoiding common data artifacts that are often introduced by alternative methods, this new software can be used to compare across forms and samples in order to more systematically obtain a well-characterized biotherapeutic product.”

With today’s update, the software now automates assignment of major isoforms, separating and visualizing subtle information from the smallest to the largest peaks without artifacts. Scientists can now mine and compare each important aspect of individual charge deconvolution with ease and without compromise, including for native mass spectra of complexes. Scientists can select and overlay any number of traces for comparison, which is a huge advance over binary mirror plotting.

Intact Mass also generates simple reports that can be configured and reconfigured without manual cutting and pasting. Intact Mass complements the other products in Protein Metrics suite of biopharmaceutical products which provide solutions for de novo sequencing, for peptide mapping, investigation of unknowns, higher order structure analysis, and the routine analysis of well-characterized biopharmaceutical products.

“These latest updates will decrease analysis time and increase knowledge for scientists investigating therapeutic proteins and release assays for reduced or intact mAbs, half- or truncated mAbs, antibody drug conjugates and therapeutic proteins with complex glycosolation,” says Dr. Carlson.

About Protein Metrics Inc.

Protein Metrics Inc. is a privately held company serving biopharmaceutical development professionals. The company focuses on the analysis of mass spectrometric and other analytical data on proteins, peptides and glycans. Seeking to ensure that software to analyze mass spec and other analytical data keeps pace with the rapid advances in instrumentation, Protein Metrics leverages its experience in mass spectrometry, computer science, and bioinformatics to make analytical results more complete, sensitive, accurate, and easier to achieve. The company is headquartered in San Carlos, California. For more information, visit www.proteinmetrics.com.

Media Contact:Eric Carlson, Protein Metrics, Inc., 408-600-5540, carlson@proteinmetrics.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE Protein Metrics Inc.

MORE ON THIS TOPIC